UNSPSC 85891032: Hyperthermia of brain stem

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of hyperthermia of brain stem. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D0Y18ZZ

UNSPSC 85891032 Hyperthermia of brain stem is a Commodity code with minimal relevant state and local procurement activity. The code nominally describes a neurological treatment procedure, but recent state and local solicitations tagged under this code do not reflect that scope. The recent opportunities block shows healthcare service procurements spanning virtual urgent care (Inland Empire Health Plan, California), medical services (DeKalb County, Georgia), PACE operations (Nevada Health Authority), cancer registry services (San Mateo County, California), employee health clinics (City of Ocala, Florida), occupational health services (multiple jurisdictions), psychiatric evaluations, EMS staffing, opioid treatment programs, and wellness platforms—none of which align with brain stem hyperthermia procedures. The mismatch suggests either systematic miscoding of healthcare service opportunities under this code or that the code has drifted from its intended medical procedure meaning in state and local procurement systems.

State and local governments are actively buying primary care, occupational health, behavioral health, emergency medical staffing, and specialized clinical services across counties, cities, health authorities, and public hospital systems in California, Georgia, Nevada, Florida, Colorado, Kansas, Texas, Arizona, and other states. However, these opportunities represent work in family medicine, public health, mental health treatment, and emergency services—not neurosurgical or neurological interventions. Because the recent solicitations are plainly unrelated to hyperthermia treatment of any kind, this code shows little actionable procurement signal for firms pursuing contracts in the stated therapeutic domain. Vendors should verify the correct UNSPSC classification before building pursuit strategy around these opportunities.